Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bristol’s Q2 Earnings Homerun Overshadowed By Clinical Trial Review Curveball
Cobenfy In Alzheimer’s Psychosis Among Next Readouts
Aug 01 2025
•
By
Mandy Jackson
BMS shares fell 5.8% on the company's disclosure of plans to review in-progress trials
(Shutterstock)
More from Earnings
More from Business